Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I-131 Doses in Graves' Disease
NCT02114619Unknown
- Sponsor
- Mashhad University of Medical Sciences
- Start
- May 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of iodine-131 in Graves' disease (3 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Change of thyroid related hormones blood level at 12 months. Status: unknown.
02
Drugs
iodine-131
03
Conditions
Graves' disease
Beyond the preview
Go deeper on NCT02114619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02114619.